Sperm cryostorage in a dry tank: An accurate alternative.

Acrosome integrity Cryostorage DNA fragmentation Dry tank Human sperm Liquid nitrogen tank Motility Vitality

Journal

Cryobiology
ISSN: 1090-2392
Titre abrégé: Cryobiology
Pays: Netherlands
ID NLM: 0006252

Informations de publication

Date de publication:
06 2020
Historique:
received: 11 02 2020
revised: 04 05 2020
accepted: 05 05 2020
pubmed: 12 5 2020
medline: 31 12 2020
entrez: 12 5 2020
Statut: ppublish

Résumé

This prospective study aimed to determine the effects of dry nitrogen cryostorage on human sperm characteristics in comparison with liquid nitrogen cryostorage. For this purpose, 42 men undergoing routine semen analysis (21 normozoospermia and 21 with altered semen parameters) were analyzed. After slow freezing, half of the straws of each sample were randomly stored in liquid and dry tanks, at the top and bottom levels of the latter. After 6 months storage, thawed samples were treated by density gradient centrifugation and sperm characteristics were compared. There was no difference in sperm progressive motility (15.1% ± 14.2% vs. 15.1% ± 12.7%; p = 0.76), sperm vitality (25.5% ± 17.7% vs. 26.2% ± 19%; p = 0.71), percentages of acrosome-reacted spermatozoa (38% ± 8.5% vs. 38.5% ± 7.4%; p = 0.53) and DNA fragmentation spermatozoa (27.3% ± 12.4% vs. 28.5% ± 12.9%, p = 0.47) after cryostorage in the dry or the liquid nitrogen tank. Moreover, we did not observe differences between either cryostorage system for normal and altered sperm samples. This lack of difference was also observed whatever the floor level of cryostorage in the dry tank. The temperature measurement of the dry tank showed a stable temperature at -194 °C throughout storage whatever the storage floor level, guaranteeing the stability of the low temperatures suitable for human sperm storage. Because of its greater safety, dry storage without contact with the liquid phase should be preferred and can be a useful alternative for the cryostorage of human sperm samples.

Identifiants

pubmed: 32389625
pii: S0011-2240(20)30068-7
doi: 10.1016/j.cryobiol.2020.05.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-39

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest There was no external funding for this study and all the authors declare no competing interests.

Auteurs

Stéphanie Mestres (S)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France. Electronic address: smestres@chu-clermontferrand.fr.

Hanae Pons-Rejraji (H)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France; Université Clermont Auvergne, IMoST, INSERM 1240, Faculté de Médecine, Place Henri Dunant, F-63000, Clermont-Ferrand, France. Electronic address: hpons-rejraji@chu-clermontferrand.fr.

Bruno Pereira (B)

CHU Clermont Ferrand, DRCI, Délégation Recherche Clinique et Innovation, Biostatistics, Place Henri Dunant, F-63000, Clermont-Ferrand, France. Electronic address: bpereira@chu-clermontferrand.fr.

Cyril Bouche (C)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France. Electronic address: c_bouche@chu-clermontferrand.fr.

Aurélie Vega (A)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France. Electronic address: avega@chu-clermontferrand.fr.

Laure Chaput (L)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France. Electronic address: lchaput1@chu-clermontferrand.fr.

Solène Vorilhon (S)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France. Electronic address: svorilhon@chu-clermontferrand.fr.

Laurent Janny (L)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France. Electronic address: ljanny@chu-clermontferrand.fr.

Florence Brugnon (F)

CHU Clermont Ferrand, CHU Estaing, Assistance Médicale à la Procréation, CECOS, 1 Place Aubrac, F-63000, Clermont-Ferrand, France; Université Clermont Auvergne, IMoST, INSERM 1240, Faculté de Médecine, Place Henri Dunant, F-63000, Clermont-Ferrand, France. Electronic address: fbrugnon@chu-clermontferrand.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH